BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yassin AS, Subahi A, Abubakar H, Akintoye E, Alhusain R, Adegbala O, Ahmed A, Elmoughrabi A, Subahi E, Pahuja M, Sahlieh A, Elder M, Kaki A, Schreiber T, Mohamad T. Outcomes and Effects of Hepatic Cirrhosis in Patients Who Underwent Transcatheter Aortic Valve Implantation. Am J Cardiol 2018;122:455-60. [PMID: 30041889 DOI: 10.1016/j.amjcard.2018.04.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Thotamgari SR, Sheth AR, Patel HP, Bretzman J, Ward RC, Thakkar S, Patel JT, Asirvatham SJ, Holmes DR, Egbe A, Deshmukh A, Desimone CV. Liver cirrhosis is independently associated with increased in-hospital mortality in patients undergoing left atrial appendage occlusion device implantation. Heart Rhythm 2022. [DOI: 10.1016/j.hrthm.2022.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ahmed T, Misumida N, Grigorian A, Tarantini G, Messerli AW. Transcatheter interventions for valvular heart diseases in liver cirrhosis patients. Trends Cardiovasc Med 2021:S1050-1738(21)00164-X. [PMID: 34974163 DOI: 10.1016/j.tcm.2021.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Takagi K, Arinaga K, Takaseya T, Otsuka H, Shojima T, Shintani Y, Kono T, Zaima Y, Kikusaki S, Saku K, Oryoji A, Tayama E. Clinical outcome of cardiac surgery in patients with remitted or active hepatocellular carcinoma. Surg Today 2021;51:1456-63. [PMID: 33555435 DOI: 10.1007/s00595-021-02239-z] [Reference Citation Analysis]
4 Okai T, Mizutani K, Hara M, Yamaguchi T, Ogawa M, Ito A, Iwata S, Izumiya Y, Takahashi Y, Shibata T, Yoshiyama M. Presence of mitral stenosis is a risk factor of new development of acute decompensated heart failure early after transcatheter aortic valve implantation. Open Heart 2020;7:e001348. [PMID: 33020257 DOI: 10.1136/openhrt-2020-001348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Khan MZ, Khan MU, Munir MB, Khan SU, Osman M, Balla S. Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease. Catheter Cardiovasc Interv 2020;96:947-55. [PMID: 32129573 DOI: 10.1002/ccd.28834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Levy C, Lassailly G, El Amrani M, Vincent F, Delhaye C, Meurice T, Boleslawski E, Millet G, Ningarhari M, Truant S, Louvet A, Mathurin P, Lebuffe G, Pruvot FR, Dharancy S. Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients. Am J Transplant 2020;20:2567-70. [PMID: 32347626 DOI: 10.1111/ajt.15955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ma X, Zhao D, Li J, Wei D, Zhang J, Yuan P, Kong X, Ma J, Ma H, Sun L, Zhang Y, Jiao Q, Wang Z, Zhang H. Transcatheter aortic valve implantation in the patients with chronic liver disease: A mini-review and meta-analysis. Medicine (Baltimore) 2020;99:e19766. [PMID: 32311980 DOI: 10.1097/MD.0000000000019766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Tinica G, Furnica C, Chistol RO. Cardiac Surgery Risks in Liver Dysfunction. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_73] [Reference Citation Analysis]
9 Takagi H, Hari Y, Kawai N, Kuno T, Ando T. Meta-analysis of impact of liver disease on mortality after transcatheter aortic valve implantation: . Journal of Cardiovascular Medicine 2019;20:237-44. [DOI: 10.2459/jcm.0000000000000777] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]